Delivery Order SPE2DB20D1004-SPE2DB25FNKRA
- Not listed
- The Defense Logistics Agency awarded a $16,451.57 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of 500 tablets of Citalopram HBR 40 mg, with completion expected by September 5, 2025. This competitively awarded contract utilizes firm fixed-price pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Citalopram HBR 40 mg tablets (500 count) valued at $3,705.96. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 4, 2025. The performance location is AmerisourceBergen Drug Corp's corporate office in Conshohocken, Pennsylvania. Citalopram is a selective serotonin reuptake inhibitor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Citalopram HBr 10 mg tablets (500 count) with a ceiling value of $10,708.82. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,959.19 to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 40 mg tablets (500 count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The product will be delivered to the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,329.50 to AmerisourceBergen Drug Corp for the supply of Citalopram HBR 40 mg tablets (500 count) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies the place of performance as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Citalopram HBr 20 mg tablets in quantities of 500 units, with a ceiling value of $13,316.99 and a firm fixed price structure. This is a non-set-aside contract, indicating the award was made through open competition. The delivery order is expected to be completed by August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Citalopram HBr 40 mg tablets in quantities of 500 units, with a ceiling value of $6,023.38. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by September 3, 2025, and will be performed at the contractor's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Citalopram Hydrobromide 40 mg tablets. The order has a ceiling value of $7,316.01 and is a firm fixed-price delivery order with a completion date of September 18, 2024. The contract does not have a set-aside designation. As a prominent supplier of pharmaceutical products and medical supplies to the federal government, AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,408.65 firm fixed-price delivery order is for the supply of 4,560,714,978 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of April 26, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Citalopram HBr 20 mg tablets (500 count) with a ceiling value of $1,733.43. This competitive award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The contract is performed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKRADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Citalopram HBR 40 mg tablets (500-count units) with a ceiling value of $12,406.14. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and a critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical supply under this delivery order supports the Defense Logistics Agency's Medical Supply Chain operations. Citalopram is a selective serotonin reuptake inhibitor used for depression treatment and is a standard medication in military healthcare formularies. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to competitively deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains to support military personnel and veteran healthcare needs. The non-set-aside competitive award reflects the company's qualification to meet federal procurement standards through open competition processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 9/10/25 |